Disciplined Equity Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Disciplined Equity Management's PFE Position: Q3 2026 in Review
Disciplined Equity Management increased its Pfizer (PFE) stake by 1.6% in Q3 2026, buying an estimated $36.2K and bringing the position to 87,920 shares worth $2.51M. The position accounts for 1.1% of the portfolio, ranked #9.
Disciplined Equity Management first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $2.69M in Q4 2021. 1,268 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Disciplined Equity Management held 87,920 shares of Pfizer worth $2.51M as of Q3 2026.
- Disciplined Equity Management bought 1,360 Pfizer shares in Q3 2026, an estimated $36.2K.
- Pfizer made up 1.1% of Disciplined Equity Management's portfolio in Q3 2026, its #9 holding.
- Disciplined Equity Management first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- Disciplined Equity Management's Pfizer position peaked at $2.69M in Q4 2021.
- 1,268 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Disciplined Equity Management's 13F filing for Q3 2026, filed 14 Oct 2026.